| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $1.84B | +15.9% |
| Cost of Revenue | $871.1M | +10.8% |
| R&D Expense | $255.1M | +2.0% |
| SG&A Expense | $433.0M | +30.8% |
| Operating Income | $475.5M | +0.3% |
| Interest Expense | $35.2M | +334.6% |
| Pre-tax Income | $443.6M | -5.1% |
| Income Tax | $46.7M | -31.4% |
| Net Income | $396.9M |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $503.3M | -26.2% |
| Short-term Investments | $33.2M | -7.7% |
| Accounts Receivable | $204.1M | +35.0% |
| Current Assets | $870.3M | -6.8% |
| Total Assets | $4.01B | +80.4% |
| Current Liabilities | $438.3M | +38.8% |
| Long-term Debt | $1.98B | +245.0% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $538.3M | -3.1% |
| Capital Expenditures | $51.2M | -16.6% |
| Investing Cash Flow | -$2.03B | -1395.4% |
| Financing Cash Flow | $1.34B | +515.0% |
| Free Cash Flow | $487.1M | -1.4% |
| -0.7% |
| EPS (Basic) | $10.48 | -0.8% |
| EPS (Diluted) | $10.25 | -1.1% |
| Total Liabilities |
| $2.68B |
| +122.0% |
| Stockholders' Equity | $1.33B | +31.0% |